As of May 21
| +0.09 / +3.72%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 2.50. The median estimate represents a -- increase from the last price of 0.00.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.